Comparative proteome analysis of spontaneous outer membrane vesicles and purified outer membranes of neisseria meningitidis

Journal of Bacteriology

Volumn 195, Issue 19, 2013, Pages 4425-4435

  Lappann, Martin ^a   Otto, Andreas ^b   Becher, Dörte ^b   Vogel, Ulrich ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NITROGEN 15; OUTER MEMBRANE PROTEIN; PEPTIDOGLYCAN; PROTEOME;

ARTICLE; BACTERIAL OUTER MEMBRANE; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAM NEGATIVE BACTERIUM; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MEMBRANE VESICLE; NEISSERIA MENINGITIDIS; NONHUMAN; OUTER MEMBRANE VESICLE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; QUANTITATIVE ANALYSIS; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING;

BACTERIAL OUTER MEMBRANE PROTEINS; GENE EXPRESSION REGULATION, BACTERIAL; NEISSERIA MENINGITIDIS; NITROGEN ISOTOPES; PORINS; PROTEIN TRANSPORT; PROTEOME;

EID: 84885466975     PISSN: 00219193     EISSN: 10985530     Source Type: Journal    
DOI: 10.1128/JB.00625-13     Document Type: Article

References (64)

1. Ellis TN, Kuehn MJ. 2010. Virulence and immunomodulatory roles of bacterial outer membrane vesicles. Microbiol. Mol. Biol. Rev. 74:81-94.
2. Kulp A, Kuehn MJ. 2010. Biological functions and biogenesis of secreted bacterial outer membrane vesicles. Annu. Rev. Microbiol. 64:163-184.
3. Berleman J, Auer M. 2013. The role of bacterial outer membrane vesicles for intra- and interspecies delivery. Environ. Microbiol. 15:347-354.
4. Pathak DT, Wei X, Bucuvalas A, Haft DH, Gerloff DL, Wall D. 2012. Cell contact-dependent outer membrane exchange in myxobacteria: genetic determinants and mechanism. PLoS Genet. 8:e1002626. doi:10.1371 /journal.pgen.1002626.
5. Kesty NC, Mason KM, Reedy M, Miller SE, Kuehn MJ. 2004. Enterotoxigenic Escherichia coli vesicles target toxin delivery into mammalian cells. EMBO J. 23:4538-4549.
6. McBroom AJ, Kuehn MJ. 2007. Release of outer membrane vesicles by Gram-negative bacteria is a novel envelope stress response. Mol. Microbiol. 63:545-558.
7. van de Waterbeemd B, Zomer G, van den Ijssel J, van Keulen L, Eppink MH, van der Ley P, van der Pol LA. 2013. Cysteine depletion causes oxidative stress and triggers outer membrane vesicle release by Neisseria meningitidis; implications for vaccine development. PLoS One 8:e54314. doi:10.1371/journal.pone.0054314.
8. Kwon SO, Gho YS, Lee JC, Kim SI. 2009. Proteome analysis of outer membrane vesicles from a clinical Acinetobacter baumannii isolate. FEMS Microbiol. Lett. 297:150-156.
9. Choi DS, Kim DK, Choi SJ, Lee J, Choi JP, Rho S, Park SH, Kim YK, Hwang D, Gho YS. 2011. Proteomic analysis of outer membrane vesicles derived from Pseudomonas aeruginosa. Proteomics 11:3424-3429.
10. Lee EY, Bang JY, Park GW, Choi DS, Kang JS, Kim HJ, Park KS, Lee JO, Kim YK, Kwon KH, Kim KP, Gho YS. 2007. Global proteomic profiling of native outer membrane vesicles derived from Escherichia coli. Proteomics 7:3143-3153.
11. Kahnt J, Aguiluz K, Koch J, Treuner-Lange A, Konovalova A, Huntley S, Hoppert M, Sogaard-Andersen L, Hedderich R. 2010. Profiling the outer membrane proteome during growth and development of the social bacterium Myxococcus xanthus by selective biotinylation and analyses of outer membrane vesicles. J. Proteome Res. 9:5197-5208.
12. Post DM, Zhang D, Eastvold JS, Teghanemt A, Gibson BW, Weiss JP. 2005. Biochemical and functional characterization of membrane blebs purified from Neisseria meningitidis serogroup B. J. Biol. Chem. 280: 38383-38394.
13. Ferrari G, Garaguso I, Adu-Bobie J, Doro F, Taddei AR, Biolchi A, Brunelli B, Giuliani MM, Pizza M, Norais N, Grandi G. 2006. Outer membrane vesicles from group B Neisseria meningitidis delta gna33 mutant: proteomic and immunological comparison with detergent-derived outer membrane vesicles. Proteomics 6:1856-1866.
14. Haurat MF, Aduse-Opoku J, Rangarajan M, Dorobantu L, Gray MR, Curtis MA, Feldman MF. 2011. Selective sorting of cargo proteins into bacterial membrane vesicles. J. Biol. Chem. 286:1269-1276.
15. Herrick WW. 1919. Extrameningeal meningococcus infection. Arch. Intern. Med. 23:409-418.
16. van Deuren M, Brandtzaeg P, van der Meer JW. 2000. Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin. Microbiol. Rev. 13:144-166, table of contents.
17. Brandtzaeg P, Kierulf P, Gaustad P, Skulberg A, Bruun JN, Halvorsen S, Sorensen E. 1989. Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J. Infect. Dis. 159: 195-204.
18. Brandtzaeg P, Bryn K, Kierulf P, Ovstebo R, Namork E, Aase B, Jantzen E. 1992. Meningococcal endotoxin in lethal septic shock plasma studied by gas chromatography, mass-spectrometry, ultracentrifugation, and electron microscopy. J. Clin. Invest. 89:816-823.
19. Lappann M, Danhof S, Guenther F, Olivares-Florez S, Mordhorst IL, Vogel U. 2013. In vitro resistance mechanisms of Neisseria meningitidis against neutrophil extracellular traps. Mol. Microbiol. 89:433-449.
20. Sierra GV, Campa HC, Varcacel NM, Garcia IL, Izquierdo PL, Sotolongo PF, Casanueva GV, Rico CO, Rodriguez CR, Terry MH 1991. Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba. NIPH Ann. 14:195-207; discussion 208-210.
21. Claassen I, Meylis J, van der Ley P, Peeters C, Brons H, Robert J, Borsboom D, van der Ark A, van Straaten I, Roholl P, Kuipers B, Poolman J. 1996. Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccine. Vaccine 14:1001-1008.
22. Keiser PB, Gibbs BT, Coster TS, Moran EE, Stoddard MB, Labrie JE, III, Schmiel DH, Pinto V, Chen P, Zollinger WD. 2010. A phase 1 study of a group B meningococcal native outer membrane vesicle vaccine made from a strain with deleted lpxL2 and synX and stable expression of opcA. Vaccine 28:6970-6976.
23. van de Waterbeemd B, Mommen GP, Pennings JL, Eppink MH, Wijffels R, van der Pol LA, de Jong AP. 15 February 2013, posting date. Quantitative proteomics reveals distinct differences in the protein content of outer membrane vesicle vaccines. J. Proteome Res. (Epub ahead of print.) doi:10.1021/pr301208g.
24. Dunn KL, Virji M, Moxon ER. 1995. Investigations into the molecular basis of meningococcal toxicity for human endothelial and epithelial cells: the synergistic effect of LPS and pili. Microb. Pathog. 18:81-96.
25. Vogel U, Morelli G, Zurth K, Claus H, Kriener E, Achtman M, Frosch M. 1998. Necessity of molecular techniques to distinguish between Neisseria meningitidis strains isolated from patients with meningococcal disease and from their healthy contacts. J. Clin. Microbiol. 36:2465-2470.
26. Baart GJ, Zomer B, de Haan A, van der Pol LA, Beuvery EC, Tramper J, Martens DE. 2007. Modeling Neisseria meningitidis metabolism: from genome to metabolic fluxes. Genome Biol. 8:R136. doi:10.1186/gb-2007 -8-7-r136.
27. Lappann M, Haagensen JA, Claus H, Vogel U, Molin S. 2006. Meningococcal biofilm formation: structure, development and phenotypes in a standardized continuous flow system. Mol. Microbiol. 62:1292-1309.
28. Harrison OB, Claus H, Jiang Y, Bennett JS, Bratcher HB, Jolley KA, Corton C, Care R, Poolman JT, Zollinger WD, Frasch CE, Stephens DS, Feavers I, Frosch M, Parkhill J, Vogel U, Quail MA, Bentley SD, Maiden MC. 2013. Description and nomenclature of Neisseria meningitidis capsule locus. Emerg. Infect. Dis. 19:566-573.
29. Heckels JE. 1977. The surface of Neisseria gonorrhoeae: isolation of the major components of the outer membrane. J. Gen. Microbiol. 99:333- 341.
30. Tsai CM, Frasch CE. 1980. Chemical analysis of major outer membrane proteins of Neisseria meningitidis: comparison of serotypes 2 and 11. J. Bacteriol. 141:169-176.
31. MacCoss MJ, Wu CC, Liu H, Sadygov R, Yates JR, III. 2003. A correlation algorithm for the automated quantitative analysis of shotgun proteomics data. Anal. Chem. 75:6912-6921.
32. Dreisbach A, Otto A, Becher D, Hammer E, Teumer A, Gouw JW, Hecker M, Volker U. 2008. Monitoring of changes in the membrane proteome during stationary phase adaptation of Bacillus subtilis using in vivo labeling techniques. Proteomics 8:2062-2076.
33. Otto A, Bernhardt J, Meyer H, Schaffer M, Herbst FA, Siebourg J, Mader U, Lalk M, Hecker M, Becher D. 2010. Systems-wide temporal proteomic profiling in glucose-starved Bacillus subtilis. Nat. Commun. 1:137. doi:10.1038/ncomms1137.
34. Tettelin H, Saunders NJ, Heidelberg J, Jeffries AC, Nelson KE, Eisen JA, Ketchum KA, Hood DW, Peden JF, Dodson RJ, Nelson WC, Gwinn ML, DeBoy R, Peterson JD, Hickey EK, Haft DH, Salzberg SL, White O, Fleischmann RD, Dougherty BA, Mason T, Ciecko A, Parksey DS, Blair E, Cittone H, Clark EB, Cotton MD, Utterback TR, Khouri H, Qin H, Vamathevan J, Gill J, Scarlato V, Masignani V, Pizza M, Grandi G, Sun L, Smith HO, Fraser CM, Moxon ER, Rappuoli R, Venter JC. 2000. Complete genome sequence of Neisseria meningitidis serogroup B strain MC58. Science 287:1809-1815.
35. Bentley SD, Vernikos GS, Snyder LA, Churcher C, Arrowsmith C, Chillingworth T, Cronin A, Davis PH, Holroyd NE, Jagels K, Maddison M, Moule S, Rabbinowitsch E, Sharp S, Unwin L, Whitehead S, Quail MA, Achtman M, Barrell B, Saunders NJ, Parkhill J. 2007. Meningococcal genetic variation mechanisms viewed through comparative analysis of serogroup C strain FAM18. PLoS Genet. 3:e23. doi:10.1371/journal .pgen.0030023.
36. Hall TA. 1999. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp. Ser. 41:95-98.
37. Park SK, Venable JD, Xu T, Yates JR, III. 2008. A quantitative analysis software tool for mass spectrometry-based proteomics. Nat. Methods 5:319-322.
38. Zybailov B, Mosley AL, Sardiu ME, Coleman MK, Florens L, Washburn MP. 2006. Statistical analysis of membrane proteome expression changes in Saccharomyces cerevisiae. J. Proteome Res. 5:2339-2347.
39. Rusniok C, Vallenet D, Floquet S, Ewles H, Mouze-Soulama C, Brown D, Lajus A, Buchrieser C, Medigue C, Glaser P, Pelicic V. 2009. NeMeSys: a biological resource for narrowing the gap between sequence and function in the human pathogen Neisseria meningitidis. Genome Biol. 10:R110. doi:10.1186/gb-2009-10-10-r110.
40. Yu NY, Wagner JR, Laird MR, Melli G, Rey S, Lo R, Dao P, Sahinalp SC, Ester M, Foster LJ, Brinkman FS. 2010. PSORTb 3.0: improved protein subcellular localization prediction with refined localization subcategories and predictive capabilities for all prokaryotes. Bioinformatics 26:1608-1615.
41. Lappann M, Claus H, van Alen T, Harmsen M, Elias J, Molin S, Vogel U. 2010. A dual role of extracellular DNA during biofilm formation of Neisseria meningitidis. Mol. Microbiol. 75:1355-1371.
42. Thompson EA, Feavers IM, Maiden MC. 2003. Antigenic diversity of meningococcal enterobactin receptor FetA, a vaccine component. Microbiology 149:1849-1858.
43. Hou VC, Moe GR, Raad Z, Wuorimaa T, Granoff DM. 2003. Conformational epitopes recognized by protective anti-neisserial surface protein A antibodies. Infect. Immun. 71:6844-6849.
44. Williams JN, Skipp PJ, Humphries HE, Christodoulides M, O'Connor CD, Heckels JE. 2007. Proteomic analysis of outer membranes and vesicles from wild-type serogroup B Neisseria meningitidis and a lipopolysaccharide-deficient mutant. Infect. Immun. 75:1364-1372.
45. Johnston KH, Holmes KK, Gotschlich EC. 1976. The serological classification of Neisseria gonorrhoeae. I. Isolation of the outer membrane complex responsible for serotypic specificity. J. Exp. Med. 143:741-758.
46. Osborn MJ, Gander JE, Parisi E, Carson J. 1972. Mechanism of assembly of the outer membrane of Salmonella typhimurium. Isolation and characterization of cytoplasmic and outer membrane. J. Biol. Chem. 247: 3962-3972.
47. Frasch CE, Gotschlich EC. 1974. An outer membrane protein of Neisseria meningitidis group B responsible for serotype specificity. J. Exp. Med. 140:87-104.
48. Adu-Bobie J, Lupetti P, Brunelli B, Granoff D, Norais N, Ferrari G, Grandi G, Rappuoli R, Pizza M. 2004. GNA33 of Neisseria meningitidis is a lipoprotein required for cell separation, membrane architecture, and virulence. Infect. Immun. 72:1914-1919.
49. van de Waterbeemd B, Mommen GP, Pennings JL, Eppink MH, Wijffels RH, van der Pol LA, de Jong AP. 15 February 2013, posting date. Quantitative proteomics reveals distinct differences in the protein content of outer membrane vesicle vaccines. J. Proteome Res. (Epub ahead of print.) doi:10.1021/pr301208g.
50. Lee EY, Choi DS, Kim KP, Gho YS. 2008. Proteomics in gram-negative bacterial outer membrane vesicles. Mass Spectrom. Rev. 27:535-555.
51. Dorward DW, Garon CF, Judd RC. 1989. Export and intercellular transfer of DNA via membrane blebs of Neisseria gonorrhoeae. J. Bacteriol. 171:2499-2505.
52. Pérez-Cruz C, Carrion O, Delgado L, Martinez G, Lopez-Iglesias C, Mercade E. 2013. A new type of outer membrane vesicles produced by the Gram-negative bacterium Shewanella vesiculosa M7T: implications for DNA content. Appl. Environ. Microbiol. 79:1874-1881.
53. van Ulsen P, Adler B, Fassler P, Gilbert M, van Schilfgaarde M, van der Ley P, van Alphen L, Tommassen J. 2006. A novel phase-variable autotransporter serine protease, AusI, of Neisseria meningitidis. Microbes Infect. 8:2088-2097.
54. Klemm P, Vejborg RM, Sherlock O. 2006. Self-associating autotransporters, SAATs: functional and structural similarities. Int. J. Med. Microbiol. 296:187-195.
55. Serruto D, Spadafina T, Ciucchi L, Lewis LA, Ram S, Tontini M, Santini L, Biolchi A, Seib KL, Giuliani MM, Donnelly JJ, Berti F, Savino S, Scarselli M, Costantino P, Kroll JS, O'Dwyer C, Qiu J, Plaut AG, Moxon R, Rappuoli R, Pizza M, Arico B. 2010. Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans. Proc. Natl. Acad. Sci. U. S. A. 107:3770-3775.
56. Arenas J, Nijland R, Rodriguez FJ, Bosma TN, Tommassen J. 2013. Involvement of three meningococcal surface-exposed proteins, the heparin-binding protein NhbA, the alpha-peptide of IgA protease and the autotransporter protease NalP, in initiation of biofilm formation. Mol. Microbiol. 87:254-268.
57. Schmitt C, Turner D, Boesl M, Abele M, Frosch M, Kurzai O. 2007. A functional two-partner secretion system contributes to adhesion of Neisseria meningitidis to epithelial cells. J. Bacteriol. 189:7968-7976.
58. Griffiths NJ, Hill DJ, Borodina E, Sessions RB, Devos NI, Feron CM, Poolman JT, Virji M. 2011. Meningococcal surface fibril (Msf) binds to activated vitronectin and inhibits the terminal complement pathway to increase serum resistance. Mol. Microbiol. 82:1129-1149.
59. Lewis LA, Ngampasutadol J, Wallace R, Reid JE, Vogel U, Ram S. 2010. The meningococcal vaccine candidate neisserial surface protein A (NspA) binds to factorHand enhances meningococcal resistance to complement. PLoS Pathog. 6:e1001027. doi:10.1371/journal.ppat.1001027.
60. Madico G, Welsch JA, Lewis LA, McNaughton A, Perlman DH, Costello CE, Ngampasutadol J, Vogel U, Granoff DM, Ram S. 2006. The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance. J. Immunol. 177:501-510.
61. Mai-Prochnow A, Webb JS, Ferrari BC, Kjelleberg S. 2006. Ecological advantages of autolysis during the development and dispersal of Pseudoalteromonas tunicata biofilms. Appl. Environ. Microbiol. 72: 5414 -5420.
62. van de Waterbeemd B, Streefland M, van der Ley P, Zomer B, van Dijken H, Martens D, Wijffels R, van der Pol L. 2010. Improved OMV vaccine against Neisseria meningitidis using genetically engineered strains and a detergent-free purification process. Vaccine 28: 4810 - 4816.
63. Grizot S, Buchanan SK. 2004. Structure of the OmpA-like domain of RmpM from Neisseria meningitidis. Mol. Microbiol. 51:1027-1037.
64. Sánchez S, Arenas J, Abel A, Criado MT, Ferreiros CM. 2005. Analysis of outer membrane protein complexes and heat-modifiable proteins in Neisseria strains using two-dimensional diagonal electrophoresis. J. Proteome Res. 4:91-95.